Your browser doesn't support javascript.
loading
Fertility treatments and the risk of preterm birth among women with subfertility: a linked-data retrospective cohort study.
Sanders, Jessica N; Simonsen, Sara E; Porucznik, Christina A; Hammoud, Ahmad O; Smith, Ken R; Stanford, Joseph B.
Afiliação
  • Sanders JN; Department of Obstetrics and Gynecology, University of Utah, S30 N 1900 E, Rm 2B200, Salt Lake City, UT, 84132, USA. Jessica.sanders@utah.edu.
  • Simonsen SE; Department of Family and Preventive Medicine, University of Utah School of Medicine, 375 Chipeta Way Ste A., Salt Lake City, UT, 84108, USA. Jessica.sanders@utah.edu.
  • Porucznik CA; University of Utah College of Nursing, 10 South 2000 East, Salt Lake City, UT, 84112, USA.
  • Hammoud AO; Department of Family and Preventive Medicine, University of Utah School of Medicine, 375 Chipeta Way Ste A., Salt Lake City, UT, 84108, USA.
  • Smith KR; Department of Obstetrics and Gynecology, University of Utah, S30 N 1900 E, Rm 2B200, Salt Lake City, UT, 84132, USA.
  • Stanford JB; University of Utah Pedigree and Population Resource (Utah Population Database), Population Sciences, Huntsman Cancer Institute, 2000 Circle of Hope, Salt Lake City, UT, 84112, USA.
Reprod Health ; 19(1): 83, 2022 Mar 29.
Article em En | MEDLINE | ID: mdl-35351163
ABSTRACT

BACKGROUND:

In vitro fertilization (IVF) births contribute to a considerable proportion of preterm birth (PTB) each year. However, there is no formal surveillance of adverse perinatal outcomes for less invasive fertility treatments. The study objective was to describe associations between fertility treatment (in vitro fertilization, intrauterine insemination, usually with ovulation drugs (IUI), or ovulation drugs alone) and preterm birth, compared to no treatment in subfertile women.

METHODS:

The Fertility Experiences Study (FES) is a retrospective cohort study conducted at the University of Utah between April 2010 and September 2012. Women with a history of primary subfertility self-reported treatment data via survey and interviews. Participant data were linked to birth certificates and fetal death records to asses for perinatal outcomes, particularly preterm birth.

RESULTS:

A total 487 birth certificates and 3 fetal death records were linked as first births for study participants who completed questionnaires. Among linked births, 19% had a PTB. After adjustment for maternal age, paternal age, maternal education, annual income, religious affiliation, female or male fertility diagnosis, and duration of subfertility, the odds ratios and 95% confidence intervals (CI) for PTB were 2.17 (CI 0.99, 4.75) for births conceived using ovulation drugs, 3.17 (CI 1.4, 7.19) for neonates conceived using IUI and 4.24 (CI 2.05, 8.77) for neonates conceived by IVF, compared to women with subfertility who used no treatment during the month of conception. A reported diagnosis of female factor infertility increased the adjusted odds of having a PTB 2.99 (CI 1.5, 5.97). Duration of pregnancy attempt was not independently associated with PTB. In restricting analyses to singleton gestation, odds ratios were not significant for any type of treatment.

CONCLUSION:

IVF, IUI, and ovulation drugs were all associated with a higher incidence of preterm birth and low birth weight, predominantly related to multiple gestation births.
Infertility treatments such as in vitro fertilization are associated with preterm birth, but less is known about how other less invasive treatments contribute to preterm birth. This study compares different types of fertility treatments and rates of preterm birth with women who are also struggling with infertility but did not use fertility treatments at the time of their pregnancy. 490 women were recruited at the University of Utah between 2010 and 2012. Participants were asked to complete a survey and were linked to birth certificate and fetal death certificate data. Women who used in vitro fertilization were 4.24 times more likely to have a preterm birth than those who used no treatment. Use of intrauterine insemination were 3.17 times more likely to have a preterm birth than those who used no treatment at time of conception. Ovulation stimulating drugs were 2.17 times more likely to have a preterm birth. Having female factor infertility was also associated with higher odds of having preterm birth. For those who are having trouble conceiving, trying less invasive treatments to achieve pregnancy might reduce their risk of preterm birth.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nascimento Prematuro / Infertilidade Feminina Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans / Male / Newborn / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nascimento Prematuro / Infertilidade Feminina Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans / Male / Newborn / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article